Vilin Bio Med Limited (NSE:VILINBIO)
28.90
+1.35 (4.90%)
Jan 23, 2026, 3:21 PM IST
Vilin Bio Med Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Cash & Equivalents | 0.9 | 0.56 | 60.49 | 0.35 | 0.39 | 0.47 | Upgrade |
Cash & Short-Term Investments | 0.9 | 0.56 | 60.49 | 0.35 | 0.39 | 0.47 | Upgrade |
Cash Growth | -98.53% | -99.07% | 17434.49% | -11.54% | -16.13% | -30.18% | Upgrade |
Accounts Receivable | 55.46 | 63.06 | 56.84 | 56.01 | 77.87 | 76.45 | Upgrade |
Other Receivables | - | - | - | - | 9.19 | 9.5 | Upgrade |
Receivables | 58.76 | 69.46 | 67.97 | 62.56 | 92.72 | 85.95 | Upgrade |
Inventory | 61.24 | 44.12 | 44.68 | 8.79 | 22.84 | 20.64 | Upgrade |
Other Current Assets | 10.76 | 11.47 | 13.02 | 8.85 | 3.14 | 12.68 | Upgrade |
Total Current Assets | 131.66 | 125.61 | 186.16 | 80.54 | 119.09 | 119.74 | Upgrade |
Property, Plant & Equipment | 30.66 | 28.53 | 13.83 | 15.12 | 16.5 | 18.69 | Upgrade |
Long-Term Accounts Receivable | 69.03 | 72.56 | 77.45 | 71.61 | - | - | Upgrade |
Other Long-Term Assets | - | - | - | - | -0 | 0.49 | Upgrade |
Total Assets | 249.98 | 277.28 | 324.04 | 176.76 | 135.58 | 138.91 | Upgrade |
Accounts Payable | 5.51 | 13.89 | 19.53 | 11.89 | 6.41 | 8.17 | Upgrade |
Accrued Expenses | - | - | - | 2.76 | 1.38 | 0.99 | Upgrade |
Short-Term Debt | - | - | - | - | - | 45 | Upgrade |
Current Portion of Long-Term Debt | 4.58 | 25.73 | 66.21 | 45 | 45.66 | - | Upgrade |
Current Income Taxes Payable | - | 5.69 | 5.69 | 5.28 | 0.25 | 0.4 | Upgrade |
Other Current Liabilities | 6.84 | 0.39 | 1.3 | 0.03 | - | - | Upgrade |
Total Current Liabilities | 16.93 | 45.7 | 92.74 | 64.97 | 53.7 | 54.56 | Upgrade |
Long-Term Debt | - | - | 2.09 | 4.31 | 7.34 | 10.16 | Upgrade |
Long-Term Deferred Tax Liabilities | - | 0.94 | 0.82 | 0.7 | 0.58 | 0.57 | Upgrade |
Other Long-Term Liabilities | 0.9 | - | -0 | -0 | - | -0 | Upgrade |
Total Liabilities | 17.83 | 46.64 | 95.64 | 69.98 | 61.62 | 65.29 | Upgrade |
Common Stock | 139.5 | 139.5 | 139.5 | 99.5 | 33 | 33 | Upgrade |
Additional Paid-In Capital | - | 80 | 80 | - | - | - | Upgrade |
Retained Earnings | - | 8.88 | 6.64 | 5.02 | 38.71 | 38.37 | Upgrade |
Comprehensive Income & Other | 92.65 | 2.26 | 2.26 | 2.26 | 2.26 | 2.26 | Upgrade |
Shareholders' Equity | 232.15 | 230.64 | 228.4 | 106.78 | 73.96 | 73.63 | Upgrade |
Total Liabilities & Equity | 249.98 | 277.28 | 324.04 | 176.76 | 135.58 | 138.91 | Upgrade |
Total Debt | 4.58 | 25.73 | 68.3 | 49.31 | 53 | 55.16 | Upgrade |
Net Cash (Debt) | -3.68 | -25.17 | -7.81 | -48.97 | -52.61 | -54.69 | Upgrade |
Net Cash Per Share | -0.26 | -1.80 | -0.56 | -4.92 | -6.38 | -6.63 | Upgrade |
Filing Date Shares Outstanding | 13.79 | 13.95 | 13.95 | 9.95 | 8.25 | 8.25 | Upgrade |
Total Common Shares Outstanding | 13.79 | 13.95 | 13.95 | 9.95 | 8.25 | 8.25 | Upgrade |
Working Capital | 114.73 | 79.91 | 93.42 | 15.58 | 65.39 | 65.18 | Upgrade |
Book Value Per Share | 16.83 | 16.53 | 16.37 | 10.73 | 8.96 | 8.92 | Upgrade |
Tangible Book Value | 232.15 | 230.64 | 228.4 | 106.78 | 73.96 | 73.63 | Upgrade |
Tangible Book Value Per Share | 16.83 | 16.53 | 16.37 | 10.73 | 8.96 | 8.92 | Upgrade |
Land | - | 2.12 | 2.12 | 2.12 | 2.12 | - | Upgrade |
Buildings | - | 34.9 | 34.9 | 34.9 | 34.9 | - | Upgrade |
Machinery | - | 56.91 | 56.85 | 56.84 | 56.54 | - | Upgrade |
Construction In Progress | - | 15.68 | - | - | - | - | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.